MedPath
NMPA Approval

Sevelamer Carbonate for Suspension

国药准字H20244815

September 3, 2024

Drug Information

碳酸司维拉姆干混悬剂

干混悬剂

2.4g

化学药品

September 3, 2024

Company Information

Applicant Company

南京市溧水经济开发区机场路18号

Manufacturing Company

南京市溧水经济开发区机场路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

碳酸司维拉姆干混悬剂 - NMPA 批准文号 | MedPath